Citations (96)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (21)
Anna Gavrilova, Maksims Zolovs, Inga Urtāne & Dins Šmits. (2023) Quantitative Adherence Level Evaluation Among Long-Term Antiretroviral Therapy Patients in Latvia. Patient Preference and Adherence 17, pages 3147-3154.
Read now
Read now
Babafemi O. Taiwo, Hela Romdhani, Marie-Hélène Lafeuille, Rhea Bhojwani, Katherine Milbers & Prina Donga. (2023) Treatment and comorbidity burden among people living with HIV: a review of systematic literature reviews. Journal of Drug Assessment 12:1, pages 1-11.
Read now
Read now
Drenna Waldrop, Raphiel Murden, Mary Claire Montilus, Monique Balthazar, Crista Irwin, Marcia Holstad & Raymond L. Ownby. (2023) Durable viral suppression among persons with HIV in the deep south: an observational study. AIDS Care 35:12, pages 1836-1843.
Read now
Read now
J. Ma, B. Luu, S. A. Ruderman, B. M. Whitney, J. O. Merrill, L. S. Mixson, R. M. Nance, L. N. Drumright, A. W. Hahn, R. J. Fredericksen, G. Chander, B. Lau, M. E. McCaul, S. Safren, C. O'Cleirigh, K. Cropsey, K. H. Mayer, W. C. Mathews, R. D. Moore, S. Napravnik, K. Christopoulos, A. Willig, J. M. Jacobson, A. Webel, G. Burkholder, M. J. Mugavero, M. S. Saag, M. M. Kitahata, H. M. Crane & J. A. C. Delaney. (2023) Alcohol and drug use severity are independently associated with antiretroviral adherence in the current treatment era. AIDS Care 0:0, pages 1-13.
Read now
Read now
Juliana de Oliveira Costa, Yalin Zhao, Sallie-Anne Pearson & Andrea L. Schaffer. (2023) Assessing the impact of implementing multiple adherence measures to antiretroviral therapy from dispensing data: a short report. AIDS Care 35:7, pages 970-975.
Read now
Read now
Derek D. Satre, Varada Sarovar, Wendy A. Leyden, Amy S. Leibowitz, Jennifer O. Lam, J. Carlo Hojilla, Thibaut Davy-Mendez, Charles B. Hare & Michael J. Silverberg. (2023) Age group differences in substance use, social support, and physical and mental health concerns among people living with HIV two years after receiving primary care-based alcohol treatment. Aging & Mental Health 27:5, pages 1011-1019.
Read now
Read now
Maria Albin Qambayot & Sarita Naidoo. (2023) Provider perspectives on antiretroviral therapy adherence among psychiatric inpatients in Botswana. African Journal of AIDS Research 22:2, pages 123-130.
Read now
Read now
Marina B Klein, Jim Young, David Ortiz-Paredes, Shouao Wang, Sharon Walmsley, Alexander Wong, Valérie Martel-Laferrière, Neora Pick, Brian Conway, Jonathan Angel, Jean-Guy Baril, Chris Fraser, Bertrand Lebouché, Darrell HS Tan, Roger Sandre, Sylvie Trottier, Hansi Peiris, Jayamarx Jayaraman & Joel Singer. (2022) Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286). Patient Preference and Adherence 16, pages 3267-3281.
Read now
Read now
Duncan Short, Xueqi Wang, Shivali Suri, Thomas K Hsu, Bryn Jones, Rob J Fredericksen, Heidi M Crane, Alexandra Musten, Jean Bacon, Yongwei Wang, Kevin A Gough, Moti Ramgopal, Jeff Berry & William B Lober. (2022) Risk Factors for Suboptimal Adherence Identified by Patient-Reported Outcomes Assessments in Routine HIV Care at 2 North American Clinics. Patient Preference and Adherence 16, pages 2461-2472.
Read now
Read now
Seth C. Kalichman, Harold Katner, Marnie Hill, Wendy Ewing & Moira O. Kalichman. (2022) Perceived sensitivity to medicines and the experience of side-effects: understanding intentional medication nonadherence among people living with HIV. Psychology, Health & Medicine 27:10, pages 2261-2272.
Read now
Read now
Olivier L. Joseph, André Hall, Samantha A. Devlin, Jared Kerman, Jessica Schmitt, Moira C. McNulty & Jessica P. Ridgway. (2022) “When you have an immune disease like HIV and there is a pandemic, you still have to pay your bills”: COVID-19-related challenges among people living with HIV and lessons for care delivery. AIDS Care 34:11, pages 1405-1412.
Read now
Read now
Glenn J. Wagner, Rachana Seelam, Risa Hoffman & Bonnie Ghosh-Dastidar. (2022) Mediators and moderators of ART adherence effects of supporting treatment adherence readiness through training (START): evidence that START helps vulnerable clients achieve better adherence. AIDS Care 34:10, pages 1249-1256.
Read now
Read now
Bruno Emond, Carmine Rossi, Aurélie Côté-Sergent, Brahim Bookhart, David Anderson, Patrick Lefebvre, Marie-Hélène Lafeuille & Prina Donga. (2022) Body mass index increase and weight gain among people living with HIV-1 initiated on single-tablet darunavir/cobicistat/emtricitabine/tenofovir alafenamide or bictegravir/emtricitabine/tenofovir alafenamide in the United States. Current Medical Research and Opinion 38:2, pages 287-298.
Read now
Read now
Quan Zhang, Xiaoming Li, Shan Qiao, Shuaifeng Liu, Zhiyong Shen & Yuejiao Zhou. (2021) Association of Hair Concentrations of Antiretrovirals with Virologic Outcomes Among People Living with HIV in Guangxi, China. Patient Preference and Adherence 15, pages 853-861.
Read now
Read now
Pagna Sok, Osaro Mgbere, Lisa Pompeii & Ekere James Essien. (2021) Evaluation of the Sociodemographic, Behavioral and Clinical Influences on Complete Antiretroviral Therapy Adherence Among HIV-Infected Adults Receiving Medical Care in Houston, Texas. HIV/AIDS - Research and Palliative Care 13, pages 539-555.
Read now
Read now
Hasiya Yusuf & Allison Agwu. (2021) Adolescents and young adults with early acquired HIV infection in the united states: unique challenges in treatment and secondary prevention. Expert Review of Anti-infective Therapy 19:4, pages 457-471.
Read now
Read now
Wing Chow, Prina Donga, Aurélie Côté-Sergent, Carmine Rossi, Patrick Lefebvre, Marie-Hélène Lafeuille, Hélène Hardy & Bruno Emond. (2020) Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide. Patient Preference and Adherence 14, pages 2315-2326.
Read now
Read now
Nyashanu Mathew, Ikhile Deborah, Thamary Karonga & Chireshe Rumbidzai. (2020) The impact of COVID-19 lockdown in a developing country: narratives of self-employed women in Ndola, Zambia. Health Care for Women International 41:11-12, pages 1370-1383.
Read now
Read now
J. Jaiswal, M. D. Francis, S. N. Singer, K. B. Dunlap, A. B. Cox & R. Greene. (2020) “Worn out”: Coping strategies for managing antiretroviral treatment fatigue among urban people of color living with HIV who were recently disengaged from outpatient HIV care. Journal of HIV/AIDS & Social Services 19:2, pages 173-187.
Read now
Read now
Brian Godman, Holly McCabe, Trudy D Leong, Debjani Mueller, Antony P. Martin, Iris Hoxha, Julius C. Mwita, Godfrey Mutashambara Rwegerera, Amos Massele, Juliana de Oliveira Costa, Renata Cristina Rezende Macedo do Nascimento, Livia Lovato Pires de Lemos, Konstantin Tachkov, Petya Milushewa, Okwen Patrick, Loveline Lum Niba, Ott Laius, Israel Sefah, Suhaj Abdulsalim, Fatemeh Soleymani, Anastasia N Guantai, Loice Achieng, Margaret Oluka, Arianit Jakupi, Konstantīns Logviss, Mohamed Azmi Hassali, Dan Kibuule, Francis Kalemeera, Mwangana Mubita, Joseph Fadare, Olayinka O. Ogunleye, Zikria Saleem, Shazhad Hussain, Tomasz Bochenek, Ileana Mardare, Alian A. Alrasheedy, Jurij Furst, Dominik Tomek, Vanda Markovic-Pekovic, Enos M. Rampamba, Abubakr Alfadl, Adefolarin A Amu, Zinhle Matsebula, Thuy Nguyen Thi Phuong, Binh Nguyen Thanh, Aubrey Chichonyi Kalungia, Trust Zaranyika, Nyasha Masuka, Ioana D. Olaru, Janney Wale, Ruaraidh Hill, Amanj Kurdi, Angela Timoney, Stephen Campbell & Johanna C. Meyer. (2020) Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries. Expert Review of Pharmacoeconomics & Outcomes Research 20:1, pages 1-26.
Read now
Read now
Dionne M Hines, Yao Ding, Rolin L Wade, Anne Beaubrun & Joshua P Cohen. (2019) Treatment Adherence And Persistence Among HIV-1 Patients Newly Starting Treatment. Patient Preference and Adherence 13, pages 1927-1939.
Read now
Read now
Articles from other publishers (75)
Giovanni Del Fabro, Palmiro Mileto, Francesco Castelli & Eugenia Quiros-Roldan. (2023) Two cases of drug induced hypersensitivity to dolutegravir-rilpivirine fixed-dose combination: A case report. International Journal of Risk & Safety in Medicine 34:2, pages 155-159.
Crossref
Crossref
Edgar T Overton, Gary Richmond, Giuliano Rizzardini, Anders Thalme, Pierre-Marie Girard, Alexander Wong, Norma Porteiro, Susan Swindells, Jacques Reynes, Sebastian Noe, Conn Harrington, Carlos Martín Español, Carolina Acuipil, Asma Aksar, Yuanyuan Wang, Susan L Ford, Herta Crauwels, Veerle van Eygen, Rodica Van Solingen-Ristea, Christine L Latham, Shanker Thiagarajah, Ronald D’Amico, Kimberly Y Smith, Kati Vandermeulen & William R Spreen. (2023) Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 Infection: 152-Week Results From ATLAS-2M, a Randomized, Open-Label, Phase 3b, Noninferiority Study. Clinical Infectious Diseases 76:9, pages 1646-1654.
Crossref
Crossref
Jean B Nachega, Kimberly K Scarsi, Monica Gandhi, Rachel K Scott, Lynne M Mofenson, Moherndran Archary, Sharon Nachman, Eric Decloedt, Elvin H Geng, Lindsay Wilson, Angeli Rawat & John W Mellors. (2023) Long-acting antiretrovirals and HIV treatment adherence. The Lancet HIV 10:5, pages e332-e342.
Crossref
Crossref
Micheline Marie Milward de Azevedo Meiners, Igor Araújo Cruz & Maria Inês de Toledo. (2023) Adherence to antiretroviral therapy and viral suppression: Analysis of three periods between 2011 and 2017 at an HIV-AIDS center, Brazil. Frontiers in Pharmacology 14.
Crossref
Crossref
Jiamin He, Zheng Zhu, Meiyan Sun, Xiaoning Liu, Junwen Yu, Lin Zhang & Hongzhou Lu. (2023) Barriers and facilitators to maintaining a high level of polypharmacy adherence in people living with HIV: A scoping review. Frontiers in Pharmacology 14.
Crossref
Crossref
Yusuke Sekine, Takashi Kawaguchi, Yusuke Kunimoto, Junichi Masuda, Ayako Numata, Atsushi Hirano, Hiroki Yagura, Masashi Ishihara, Shinichi Hikasa, Mariko Tsukiji, Tempei Miyaji, Takuhiro Yamaguchi, Ei Kinai & Kagehiro Amano. (2023) Adherence to anti-retroviral therapy, decisional conflicts, and health-related quality of life among treatment-naïve individuals living with HIV: a DEARS-J observational study. Journal of Pharmaceutical Health Care and Sciences 9:1.
Crossref
Crossref
Jane C. Lindsey, Michael Hudgens, Aditya H. Gaur, Keith J. Horvath, Ronald Dallas, Barbara Heckman, Megan Mueller Johnson & K. Rivet Amico. (2023) Electronic Dose Monitoring Device Patterns in Youth Living With HIV Enrolled in an Adherence Intervention Clinical Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes 92:3, pages 231-241.
Crossref
Crossref
Karam Mounzer, Laurence Brunet, Jennifer S. Fusco, Ian R. McNicholl, Megan Dunbar, Michael Sension, Lewis H. McCurdy & Gregory P. Fusco. (2023)
Immune response to
ART
initiation in advanced
HIV
infection
. HIV Medicine.
Crossref
Crossref
Yoji Inoue, Shinichi Oka, Seiji Yokoyama, Koichi Hasegawa, Jörg Mahlich, Ulrike Schaede, Noriyuki Habuka & Yoko Murata. (2023) Medication Adherence of People Living with HIV in Japan—A Cross-Sectional Study. Healthcare 11:4, pages 451.
Crossref
Crossref
Louis S. Matza, Timothy A. Howell, Vasiliki Chounta & Nicolas van de Velde. (2022) Patient preferences and health state utilities associated with the treatment process of antiretroviral therapy for people living with HIV. Quality of Life Research 32:2, pages 531-541.
Crossref
Crossref
Setyo Adiningsih, Mirna Widiyanti & Muhammad F. Rokhmad. 2023. Proceedings of the 1st International Conference for Health Research – BRIN (ICHR 2022). Proceedings of the 1st International Conference for Health Research – BRIN (ICHR 2022)
158
169
.
Franco Maggiolo, Giuliano Rizzardini, Jean‐Michel Molina, Federico Pulido, Stephane De Wit, Linos Vandekerckhove, Juan Berenguer, Michelle L. D'Antoni, Christiana Blair, Susan K. Chuck, David Piontkowsky, Hal Martin, Richard Haubrich, Ian R. McNicholl & Joel Gallant. (2022)
Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with
HIV
: Results of a 96‐week, phase 3b, open‐label, switch trial in virologically suppressed people ≥65 years of age
. HIV Medicine 24:1, pages 27-36.
Crossref
Crossref
Mathumalar Loganathan Fahrni, Nurul Fatin Laila Misran, Zarena Zainul Abidin, Suresh Kumar Chidambaram & Antonio Ivan Lazzarino. (2023) Clinical predictors of efavirenz-based regimen treatment durability: A two-year case-control study of antiretroviral-naïve patients. Journal of Infection and Public Health 16:1, pages 96-103.
Crossref
Crossref
Muhamad Alif Bin Ibrahim & Lai Peng Ho. 2023. Handbook of Social Sciences and Global Public Health. Handbook of Social Sciences and Global Public Health
1
22
.
Muhamad Alif Bin Ibrahim & Lai Peng Ho. 2023. Handbook of Social Sciences and Global Public Health. Handbook of Social Sciences and Global Public Health
1
22
.
Yuan-ni Wu, Hai Yu, Lianfeng Lu, Xiaodi Li, Xiaosheng Liu, Wei Cao & Taisheng Li. (2022) Safety and efficacy of long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection: a systematic review and meta-analysis protocol. BMJ Open 12:12, pages e063089.
Crossref
Crossref
Lora L. Sabin, Elizabeth Simmons, Nafisa Halim, Davidson H. Hamer, Allen L. Gifford, Rebecca L. West, Anna Larson, Rachael Bonawitz, Philip Aroda, Bolanle Banigbe, Alayna J. Holderman, Lisa Murray, Mary B. DeSilva, Julia Gasuza, Barbara Mukasa & Lisa J. Messersmith. (2022) Real-time Feedback to Improve HIV Treatment Adherence in Pregnant and Postpartum Women in Uganda: A Randomized Controlled Trial. AIDS and Behavior 26:12, pages 3834-3847.
Crossref
Crossref
Tariro Ndoro, Ntombizodwa Ndlovu & Peter Nyasulu. (2022) Factors associated with ART adherence among HIV-positive adherence club members in Ekurhuleni Metropolitan Municipality, South Africa: A cross-sectional study. PLOS ONE 17:11, pages e0277039.
Crossref
Crossref
Stefanella Costa-Cordella, Alejandra Rossi, Aitana Grasso-Cladera, Javiera Duarte & Claudia P. Cortes. (2022) Characteristics of psychosocial interventions to improve ART adherence in people living with HIV: A systematic review. PLOS Global Public Health 2:10, pages e0000956.
Crossref
Crossref
Marta Celesia, Vittoria Moscatt, Alessandra Tzannis, Michele Trezzi, Emanuele Focà, Margherita Errico, Paola Cinque, Silvia Nozza, Antonella Cingolani, Manuela Ceccarelli & Benedetto M. Celesia. (2022) Long-acting drugs: people’s expectations and physicians’ preparedness. Are we readying to manage it? An Italian survey. Medicine 101:42, pages e30052.
Crossref
Crossref
Kaja Scheibe, Anna Urbańska, Karol Serwin & Miłosz Parczewski. (2022) Frequency of genotypic factors possibly associated with cabotegravir/rilpivirine failure in antiretroviral treatment-naïve and -experienced HIV-1- infected population. Infection, Genetics and Evolution 104, pages 105358.
Crossref
Crossref
Shamimul Hasan, Mohd. Aqil & Rajat Panigrahi. (2022) HIV-Associated Systemic Sclerosis: Literature Review and a Rare Case Report. International Journal of Environmental Research and Public Health 19:16, pages 10066.
Crossref
Crossref
Ryan P. Coyle, Mary Morrow, Samantha MaWhinney, Stacey S. Coleman, Jia‐Hua Zheng, Lucas Ellison, Lane R. Bushman, Jennifer J. Kiser, Peter L. Anderson & Jose R. Castillo‐Mancilla. (2022)
Cumulative tenofovir diphosphate exposure in persons with
HIV
taking single‐ vs. multiple‐tablet regimens
. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 42:8, pages 641-650.
Crossref
Crossref
Chinyere Okoli, Laurent Finkielsztejn, Ama Appiah, Pascal Pugliese, Corinne Fructuoso & Patricia de los Rios. (2022) Comorbidities, comedications and polypharmacy among people living with HIV and associated challenges with HIV antiretroviral therapy: Findings from people living with HIV in four countries in Western Europe. Population Medicine 4:July, pages 1-16.
Crossref
Crossref
Laia Pérez-Cordón, Azhara Sánchez, Sergio Marin, Lluis Force, Mateu Serra-Prat, Elisabet Palomera & Lluis Campins. (2022) Real-world effectiveness and durability of dual antiretroviral therapy in HIV-infected patients. European Journal of Hospital Pharmacy, pages ejhpharm-2022-003277.
Crossref
Crossref
Simone J Skeen, Stephen Scott Jones, Carolyn Marie Cruse & Keith J Horvath. (2022) Integrating Natural Language Processing and Interpretive Thematic Analyses to Gain Human-Centered Design Insights on HIV Mobile Health: Proof-of-Concept Analysis. JMIR Human Factors 9:3, pages e37350.
Crossref
Crossref
Rima K. Acosta, Michelle L. D’Antoni, Andrew Mulato, Stephen R. Yant, Tomas Cihlar & Kirsten L. White. (2022)
Forgiveness of INSTI-Containing Regimens at Drug Concentrations Simulating Variable Adherence
In Vitro
. Antimicrobial Agents and Chemotherapy 66:5.
Crossref
Crossref
Sian Raubinger, Frederick J. Lee & Angie N. Pinto. (2022)
HIV
: the changing paradigm
. Internal Medicine Journal 52:4, pages 542-549.
Crossref
Crossref
Tyrel J. Starks, Simone J. Skeen, S. Scott Jones, Sitaji Gurung, Brett M. Millar, Christopher Ferraris, Ana Ventuneac, Jeffrey T. Parsons & Martha A. Sparks. (2021) Effectiveness of a Combined Motivational Interviewing and Cognitive Behavioral Intervention to Reduce Substance Use and Improve HIV-Related Immune Functioning. AIDS and Behavior 26:4, pages 1138-1152.
Crossref
Crossref
Nadine Mayasi, Hippolyte Situakibanza, Marcel Mbula, Murielle Longokolo, Nathalie Maes, Ben Bepouka, Jérôme Odio Ossam, Michel Moutschen & Gilles Darcis. (2022) Retention in care and predictors of attrition among HIV-infected patients who started antiretroviral therapy in Kinshasa, DRC, before and after the implementation of the ‘treat-all’ strategy. PLOS Global Public Health 2:3, pages e0000259.
Crossref
Crossref
Yerina S Ranjit, Archana Krishnan, Debarchana Ghosh, Claire Cravero, Xin Zhou & Frederick L Altice. (2022) mHealth Intervention to Improve Treatment Outcomes Among People With HIV Who Use Cocaine: Protocol for a Pilot Randomized Controlled Trial. JMIR Research Protocols 11:3, pages e28332.
Crossref
Crossref
Karam Mounzer, Laurence Brunet, Jennifer S Fusco, Ian R Mcnicholl, Helena Diaz Cuervo, Michael Sension, Lewis Mccurdy & Gregory P Fusco. (2022) Advanced HIV Infection in Treatment-Naïve Individuals: Effectiveness and Persistence of Recommended 3-Drug Regimens. Open Forum Infectious Diseases 9:3.
Crossref
Crossref
Sophie Degroote, Linos Vandekerckhove, Dirk Vogelaers & Charlotte Vanden Bulcke. (2022) Patient-reported outcomes among people living with HIV on single- versus multi-tablet regimens: Data from a real-life setting. PLOS ONE 17:1, pages e0262533.
Crossref
Crossref
Pascal C. Baumgartner, Bernard Vrijens, Samuel Allemann, Kurt E. Hersberger & Isabelle Arnet. (2022) Delta T, a Useful Indicator for Pharmacy Dispensing Data to Monitor Medication Adherence. Pharmaceutics 14:1, pages 103.
Crossref
Crossref
Ricardo Sánchez Medina, María de los Ángeles Estrada Martínez, Consuelo Rubi Rosales Piña, David Javier Enríquez Negrete & Maria Fernanda Lozano Quiroz. (2022) Conocimientos y percepción de estudiantes de psicología sobre el trabajo profesional en personas con VIH. Revista Digital Internacional de Psicología y Ciencia Social 8:1.
Crossref
Crossref
I.A. Narkevich, O.D. Nemyatykh, D.M. Medvedeva, K.M. Akpaeva, Z.B. Sakipova, A.B. Shukirbekova & Zh.V. Mironenkova. (2022) Consumption of antiretroviral drugs in the Republic of Kazakhstan. Medical Technologies. Assessment and Choice 44:2, pages 22.
Crossref
Crossref
Derek T. Dangerfield, Allison J. Ober, Michael J. Li, Sophia Allen & Ricky N. Bluthenthal. (2022) HIV Treatment Adherence Strategies Among Virally Suppressed Black Sexual Minority Men in Baltimore, Maryland, and Los Angeles, California: A Theory-Based Qualitative Study. Journal of the Association of Nurses in AIDS Care 33:1, pages 54-62.
Crossref
Crossref
Olumuyiwa E Ariyo & Christopher E Jones. (2022) Use of long-acting injectable antiretroviral agents for human immunodeficiency Virus: A review. Journal of Clinical Virology 146, pages 105032.
Crossref
Crossref
Aruna Chandran, Fiona Bhondoekhan, Tracey E. Wilson, Joel Milam, Mardge H. Cohen, Adaora A. Adimora, Adebola Adedimeji, Jennifer Cocohoba, Carrigan Parish, Marcia Holstad, Seble Kassaye & Mirjam-Colette Kempf. (2021) Intensity of Social Support Matters: A Latent Class Analysis to Identify Levels of Social Support Associated with Optimal Health Outcomes Among Women Living with HIV. AIDS and Behavior 26:1, pages 243-251.
Crossref
Crossref
Christine Gilles, Maude Velghe-lenelle, Yannick Manigart, Déborah Konopnicki & Serge Rozenberg. (2021) Should the management of high grade cervical squamous intraepithelial lesion (HSIL) be different in HIV-positive women?. AIDS Research and Therapy 18:1.
Crossref
Crossref
Lei He, Bin Yu, Jun Yu, Jun Xiong, Yuling Huang, Tian Xie, Qi Chai, Bo Gao & Shujuan Yang. (2021) The impact of social capital and mental health on medication adherence among older people living with HIV (PLWH). BMC Public Health 21:1.
Crossref
Crossref
Georgia Vourli, Ioannis Katsarolis, Nikos Pantazis & Giota Touloumi. (2021) HIV continuum of care: expanding scope beyond a cross-sectional view to include time analysis: a systematic review. BMC Public Health 21:1.
Crossref
Crossref
Robin Brünn, Beate S. Müller, Benno Flaig, Petra Kellermann-Mühlhoff, Ute Karbach, Sara Söling, Christiane Muth, Marjan van den Akker, Lara Düvel, Till Beckmann, Reinhard Hammerschmidt, Julia Jachmich, Eva Leicher, Benjamin Brandt, Johanna Richard, Frank Meyer, Mathias Flume, Thomas Müller, Ferdinand M. Gerlach, Ana Isabel González-González, Truc Sophia Dinh, Kiran Chapidi, Peter Ihle, Ingo Meyer, Nina Timmesfeld, Hans Joachim Trampisch, Renate Klaaßen-Mielke, Jale Basten, Wolfgang Greiner, Bastian Surmann, Holger Pfaff, Juliane Köberlein-Neu, Alexandra Piotrowski, Karolina Beifuß, Sarah Meyer, Daniel Grandt & Simone Grandt. (2021) “I must, and I can live with that”: a thematic analysis of patients’ perspectives on polypharmacy and a digital decision support system for GPs. BMC Family Practice 22:1.
Crossref
Crossref
Hans Jaeger, Edgar T Overton, Gary Richmond, Giuliano Rizzardini, Jaime Federico Andrade-Villanueva, Rosie Mngqibisa, Antonio Ocampo Hermida, Anders Thalme, Elena Belonosova, Faïza Ajana, Paul D Benn, Yuanyuan Wang, Krischan J Hudson, Carlos Martín Español, Susan L Ford, Herta Crauwels, David A Margolis, Christine L Talarico, Kimberly Y Smith, Veerle van Eygen, Rodica Van Solingen-Ristea, Simon Vanveggel & William R Spreen. (2021) Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 96-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study. The Lancet HIV 8:11, pages e679-e689.
Crossref
Crossref
Glenn J. Wagner, Risa Hoffman, Sebastian Linnemayr, Stefan Schneider, Daniel Ramirez, Kyle Gordon, Rachana Seelam & Bonnie Ghosh-Dastidar. (2021) START (Supporting Treatment Adherence Readiness through Training) Improves Both HIV Antiretroviral Adherence and Viral Reduction, and is Cost Effective: Results of a Multi-site Randomized Controlled Trial. AIDS and Behavior 25:10, pages 3159-3171.
Crossref
Crossref
Antonio Antela, Antonio Rivero, Josep M Llibre, Santiago Moreno, Antonio Antela, Josep M Llibre, Santiago Moreno, Antonio Rivero, Marta Alonso Montero, Enrique Bernal, José Ramón Blanco Ramos, Manuel Castaño, David Dalmau Juanola, Belén de la Fuente García, Carlos Dueñas, Nuria Espinosa, Vicente Estrada, María José Galindo Puerto, Miguel García del Toro, Juan González, Miguel Górgolas, Carmen Hidalgo-Tenorio, Hernando Knobel Freu, Juan Carlos López Bernaldo de Quirós, Juan Macías Sánchez, Carlos Martín Ruíz, Esteban Martínez Chamorro, Mar Masía, Máximo Miguelez, Celia Miralles, Julián Olalla, Esteban Ribera Pascuet, Francisco Rodríguez-Vidigal, Rafael Rubio & Santos Jesús. (2021) Redefining therapeutic success in HIV patients: an expert view. Journal of Antimicrobial Chemotherapy 76:10, pages 2501-2518.
Crossref
Crossref
Robera Olana Fite. (2021) Association between adherence to Antiretroviral Therapy and place of residence among adult HIV infected patients in Ethiopia: A systematic review and meta-analysis. PLOS ONE 16:9, pages e0256948.
Crossref
Crossref
Grace A. McComsey, Melissa Lingohr-Smith, Rachel Rogers, Jay Lin & Prina Donga. (2021) Real-World Adherence to Antiretroviral Therapy Among HIV-1 Patients Across the United States. Advances in Therapy 38:9, pages 4961-4974.
Crossref
Crossref
Babatunde Akinwunmi, Daniel Buchenberger, Jenny Scherzer, Martina Bode, Paolo Rizzini, Fabio Vecchio, Laetitia Roustand, Gaelle Nachbaur, Laurent Finkielsztejn, Vasiliki Chounta & Nicolas Van de Velde. (2021) Dose-related and contextual aspects of suboptimal adherence to antiretroviral therapy among persons living with HIV in Western Europe. European Journal of Public Health 31:3, pages 567-575.
Crossref
Crossref
Karam Mounzer, Laurence Brunet, Christina M. Wyatt, Jennifer S. Fusco, Vani Vannappagari, Allan R. Tenorio, Mark S. Shaefer, Leigh Ragone, Ricky K. Hsu & Gregory P. Fusco. (2021) To dose-adjust or not to dose-adjust: lamivudine dose in kidney impairment. AIDS 35:8, pages 1201-1208.
Crossref
Crossref
Harry Jin, Katie Biello, Robert Garofalo, Mark Lurie, Patrick S. Sullivan, Rob Stephenson & Matthew J. Mimiaga. (2021) Better Communication Regarding Sexual Agreements Within Serodiscordant Male Couples Leads to Improved Antiretroviral Therapy Adherence Among the HIV-Positive Partner. Archives of Sexual Behavior 50:4, pages 1771-1779.
Crossref
Crossref
Chinyere Okoli, Garry Brough, Brent Allan, Erika Castellanos, Benjamin Young, Anton Eremin, Giulio Maria Corbelli, Marta Mc Britton, Marvelous Muchenje, Nicolas Van de Velde & Patricia de los Rios. (2020) Shared Decision Making Between Patients and Healthcare Providers and its Association with Favorable Health Outcomes Among People Living with HIV. AIDS and Behavior 25:5, pages 1384-1395.
Crossref
Crossref
Lam Van Nguyen, Thao N. P. Nguyen, Anh N. Thach, Anh N. Lam, Duc Q. Lam, Chu X. Duong, Suol T. Pham, Thao H. Nguyen, Dyah A. Perwitasari, Katja Taxis, Phuong M. Nguyen & Thang Nguyen. (2021) Knowledge of Antiretroviral Treatment and Associated Factors in HIV-Infected Patients. Healthcare 9:4, pages 483.
Crossref
Crossref
Shaneice Fletcher-Hildebrand, Hubert Alimezelli, Tracey Carr, Karen Lawson, Anum Ali & Gary Groot. (2021) Understanding the impact of a residential housing programme for people living with HIV/AIDS: a realist evaluation protocol. BMJ Open 11:4, pages e044522.
Crossref
Crossref
Jennifer O. Lam, Craig E. Hou, J. Carlo Hojilla, Alexandra N. Anderson, Paola Gilsanz, Stacey E. Alexeeff, Tory Levine-Hall, Nicole Hood, Catherine Lee, Derek D. Satre & Michael J. Silverberg. (2021) Comparison of dementia risk after age 50 between individuals with and without HIV infection. AIDS 35:5, pages 821-828.
Crossref
Crossref
Chloe Orkin, Shinichi Oka, Patrick Philibert, Cynthia Brinson, Ayesha Bassa, Denis Gusev, Olaf Degen, Juan González García, Enrique Bernal Morell, Darrell H S Tan, Ronald D'Amico, David Dorey, Sandy Griffith, Shanker Thiagarajah, Marty St Clair, Rodica Van Solingen-Ristea, Herta Crauwels, Susan L Ford, Parul Patel, Vasiliki Chounta, Simon Vanveggel, Amy Cutrell, Veerle Van Eygen, Kati Vandermeulen, David A Margolis, Kimberly Y Smith & William R Spreen. (2021) Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study. The Lancet HIV 8:4, pages e185-e196.
Crossref
Crossref
Manish Soneja, Anivita Aggarwal, Parul Kodan & Nitin Gupta. (2021) Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient. Oxford Medical Case Reports 2021:3.
Crossref
Crossref
Marwân-al-Qays Bousmah, Marie Libérée Nishimwe, Tamara Tovar-Sanchez, Martial Lantche Wandji, Mireille Mpoudi-Etame, Gwenaëlle Maradan, Pierrette Omgba Bassega, Marie Varloteaux, Alice Montoyo, Charles Kouanfack, Eric Delaporte & Sylvie Boyer. (2020) Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial). PharmacoEconomics 39:3, pages 331-343.
Crossref
Crossref
Georgia Vourli, Teymur Noori, Anastasia Pharris, Kholoud Porter, Maria Axelsson, Josip Begovac, Francoise Cazein, Dominique Costagliola, Susan Cowan, Sara Croxford, Antonella d’Arminio Monforte, Valerie Delpech, Asunción Díaz, Enrico Girardi, Barbara Gunsenheimer-Bartmeyer, Victoria Hernando, Gisela Leierer, Florence Lot, Olivier Nunez, Niels Obel, Eline Op de Coul, Dimitra Paraskeva, Stavros Patrinos, Peter Reiss, Daniela Schmid, Anders Sonnerborg, Barbara Suligoi, Virginie Supervie, Ard van Sighem, Robert Zangerle & Giota Touloumi. (2020) Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?. Clinical Infectious Diseases 71:11, pages 2905-2916.
Crossref
Crossref
Joshua Cohen, Anne Beaubrun, Richa Bashyal, Ahong Huang, Jieni Li & Onur Baser. (2020) Real-world adherence and persistence for newly-prescribed HIV treatment: single versus multiple tablet regimen comparison among US medicaid beneficiaries. AIDS Research and Therapy 17:1.
Crossref
Crossref
Quan Zhang, Xiaoming Li, Shan Qiao, Zhiyong Shen & Yuejiao Zhou. (2020) Comparing self-reported medication adherence measures with hair antiretroviral concentration among people living with HIV in Guangxi, China. AIDS Research and Therapy 17:1.
Crossref
Crossref
Barbara A. Santevecchi, Stacy Miller & Lindsey M. Childs-Kean. (2020) Doing More With Less: Review of Dolutegravir-Lamivudine, a Novel Single-Tablet Regimen for Antiretroviral-Naïve Adults With HIV-1 Infection. Annals of Pharmacotherapy 54:12, pages 1252-1259.
Crossref
Crossref
Lucy GrahamMary Beth Flynn Makic. (2020) Nursing Considerations for Patients With HIV in Critical Care Settings. AACN Advanced Critical Care 31:3, pages 308-317.
Crossref
Crossref
Ali Judd, Diane Melvin, Lindsay C. Thompson, Caroline Foster, Marthe Le Prevost, Michael Evangeli, Alan Winston, Alejandro Arenas-Pinto, Kate Sturgeon, Katie Rowson, Diana M. Gibb & Hannah Castro. (2020) Factors Associated With Nonadherence to Antiretroviral Therapy Among Young People Living With Perinatally Acquired HIV in England. Journal of the Association of Nurses in AIDS Care 31:5, pages 574-586.
Crossref
Crossref
Andrea Gori, Andrea Antinori, Alessandra Vergori, Maria Vittoria Cossu, Barbara Menzaghi, Gaetana Sterrantino, Stefano Rusconi, Anna Maria Cattelan, Francesco Castelli, Nicola Gianotti, Giancarlo Orofino, Diego Ripamonti, Stefano Savinelli, Elio Manzillo, Teresa Antonia Santantonio, Benedetto Maurizio Celesia, Roberto Cauda, Renato Maserati, Antonella d'Arminio Monforte, Christof Stingone, Stefano Bonora, Alessia Uglietti, Roberta Termini, Francesco Rucci & Daniela Mancusi. (2020) Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor–Based Regimen: The “STORE” Study. JAIDS Journal of Acquired Immune Deficiency Syndromes 84:3, pages 290-294.
Crossref
Crossref
Markus Bickel, Christian Hoffmann, Eva Wolf, Axel Baumgarten, Christoph Wyen, Christoph D. Spinner, Hans Jäger, Nils Postel, Stefan Esser, Markus Mueller, Albrecht Stoehr, Stefan Preis, Stephan Klauke & Knud Schewe. (2020) High effectiveness of recommended first-line antiretroviral therapies in Germany: a nationwide, prospective cohort study. Infection 48:3, pages 453-461.
Crossref
Crossref
Derek D. Satre, Varada Sarovar, Wendy Leyden, Charles B. Hare, Sheryl L. Catz, Kendall J. Bryant, Emily C. Williams, J. Carlo Hojilla, Michael A. Horberg & Michael J. Silverberg. (2019) Changes in Days of Unhealthy Alcohol Use and Antiretroviral Therapy Adherence, HIV RNA Levels, and Condomless Sex: A Secondary Analysis of Clinical Trial Data. AIDS and Behavior 24:6, pages 1784-1792.
Crossref
Crossref
Ana Baumgartner, Katarina Drame, Stijn Geutjens & Marja Airaksinen. (2020) Does the Polypill Improve Patient Adherence Compared to Its Individual Formulations? A Systematic Review. Pharmaceutics 12:2, pages 190.
Crossref
Crossref
Benjamin R. Bavinton & Alison J. Rodger. (2020) Undetectable viral load and HIV transmission dynamics on an individual and population level. Current Opinion in Infectious Diseases 33:1, pages 20-27.
Crossref
Crossref
Juliana de Oliveira CostaAndrea L. SchafferNicholas A. MedlandMelisa LitchfieldSujita W. NarayanRebecca GuyHamish McManusSallie-Anne Pearson. (2020) Adherence to Antiretroviral Regimens in Australia: A Nationwide Cohort Study. AIDS Patient Care and STDs 34:2, pages 81-91.
Crossref
Crossref
Richard Makurumidze, Tsitsi Mutasa-Apollo, Tom Decroo, Regis C. Choto, Kudakwashe C. Takarinda, Janet Dzangare, Lutgarde Lynen, Wim Van Damme, James Hakim, Tapuwa Magure, Owen Mugurungi & Simbarashe Rusakaniko. (2020) Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe’s national antiretroviral therapy programme between 2012 and 2015. PLOS ONE 15:1, pages e0222309.
Crossref
Crossref
Wendel Mombaque dos Santos, Marcelo Ribeiro Primeira, Larissa Garcia de Paiva & Stela Maris de Mello Padoin. (2020) Economic and epidemiological evaluation of text message-based interventions in patients with the Human Immunodeficiency Virus. Revista Latino-Americana de Enfermagem 28.
Crossref
Crossref
Caroline Foster, Sara Ayers & Sarah Fidler. (2020) Antiretroviral adherence for adolescents growing up with HIV: understanding real life, drug delivery and forgiveness. Therapeutic Advances in Infectious Disease 7, pages 204993612092017.
Crossref
Crossref
Lesley J. Scott. (2019) Dolutegravir/Lamivudine Single-Tablet Regimen: A Review in HIV-1 Infection. Drugs 80:1, pages 61-72.
Crossref
Crossref
Robert Heglar, Rodney Mood, Julie L Priest, Kathy L Schulman & Gregory P Fusco. (2019) Benchmarking HIV Quality Measures in the US OPERA HIV Cohort. Open Forum Infectious Diseases 6:10.
Crossref
Crossref